Overlap in symptoms of rheumatic flare and COVID-19 may delay diagnosis

People with rheumatic diseases are more likely to suffer from severe symptoms of COVID-19. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours […]

Read More…

Sjögren’s syndrome

This is the lay version of the EULAR recommendations for the use of topical and systemic treatments in people with Sjögren’s syndrome. The original publication can be downloaded from the EULAR website: www.eular.org. Ramos-Casals M, et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3–18. doi:10.1136/annrheumdis-2019-216114 Introduction […]

Read More…

ACR-EULAR criteria can be used in Japanese people to diagnose primary Sjögren’s syndrome

The ACR-EULAR criteria are more likely to correctly diagnose cases of primary Sjögren’s syndrome, compared with other currently available criteria, but it may also record false positives. INTRODUCTION Sjögren’s syndrome (pronounced show-grans) is an immune disorder that affects the glands in the body that produce mucous fluids, such as saliva or tears. The main symptoms […]

Read More…

Systemic disease at diagnosis predicts earlier death in Sjögren syndome

People with evidence of systemic disease at the time of diagnosis have reduced long-term survival compared to people with simple sicca or dryness symptoms. INTRODUCTION Sjögren syndrome is an autoimmune disease where the body’s immune system attacks glands that produce fluids, for example the lacrimal and salivary glands. The disease mainly affects women between the […]

Read More…